Kewaunee Scientific Balance Sheet Health
Financial Health criteria checks 5/6
Kewaunee Scientific has a total shareholder equity of $57.5M and total debt of $31.6M, which brings its debt-to-equity ratio to 54.9%. Its total assets and total liabilities are $132.0M and $74.5M respectively. Kewaunee Scientific's EBIT is $12.9M making its interest coverage ratio 7. It has cash and short-term investments of $24.2M.
Key information
54.9%
Debt to equity ratio
US$31.59m
Debt
| Interest coverage ratio | 7x |
| Cash | US$24.21m |
| Equity | US$57.51m |
| Total liabilities | US$74.51m |
| Total assets | US$132.02m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KEW's short term assets ($92.7M) exceed its short term liabilities ($36.7M).
Long Term Liabilities: KEW's short term assets ($92.7M) exceed its long term liabilities ($37.8M).
Debt to Equity History and Analysis
Debt Level: KEW's net debt to equity ratio (12.8%) is considered satisfactory.
Reducing Debt: KEW's debt to equity ratio has increased from 29.7% to 54.9% over the past 5 years.
Debt Coverage: KEW's debt is well covered by operating cash flow (33.6%).
Interest Coverage: KEW's interest payments on its debt are well covered by EBIT (7x coverage).